Research ArticleArticle
Updating the OMERACT Filter: Core Areas as a Basis for Defining Core Outcome Sets
John R. Kirwan, Maarten Boers, Sarah Hewlett, Dorcas Beaton, Clifton O. Bingham III, Ernest Choy, Philip G. Conaghan, Maria-Antonietta D’Agostino, Maxime Dougados, Daniel E. Furst, Francis Guillemin, Laure Gossec, Désirée M. van der Heijde, Margreet Kloppenburg, Tore K. Kvien, Robert B.M. Landewé, Sarah L. Mackie, Eric L. Matteson, Philip J. Mease, Peter A. Merkel, Mikkel Ostergaard, Lesley Ann Saketkoo, Lee Simon, Jasvinder A. Singh, Vibeke Strand and Peter Tugwell
The Journal of Rheumatology March 2014, jrheum.131309; DOI: https://doi.org/10.3899/jrheum.131309
John R. Kirwan
From the University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; University of California, Geffen School of Medicine, Los Angeles, California, USA; Université de Lorraine, Université Paris Descartes, Nancy; Université Pierre et Marie Curie (UPMC), Paris; AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, the Netherlands; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds, Leeds, UK; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Seattle Rheumatology Associates, Swedish Medical Center Rheumatology Research Division, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Dr. Matteson is supported in part by grants from Novartis, the American College of Rheumatology, and the European League Against Rheumatism; and was a consultant to Horizon Pharmaceuticals; Dr. Singh received research grants from Takeda and Savient, consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals and Novartis; is a member of the OMERACT executive, which receives arms-length funding from 36 companies; and is a member of the American College of Rheumatology’s Guidelines Subcommittee of the Quality of Care Committee and the Veterans Affairs Rheumatology Field Advisory Committee. J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, and NIHR Leeds Musculoskeletal Biomedical Research Unit; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Furst, MD, University of California, Geffen School of Medicine; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes; L. Gossec, MD, PhD, UPMC—Paris 6, Groupe de Recherche Clinique-UPMC 08 (EEMOIS) and AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Kloppenburg, MD, PhD, Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; S.L. Mackie, PhD, MD, NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds; E.L. Matteson, MD, MPH, Division of Rheumatology, Mayo Clinic College of Medicine; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; P. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.A. Saketkoo, MD, MPH, Section of Rheumatology, Louisiana State University Health Sciences Center; L.S. Simon, MD, SDG LLC; J.A. Singh, MBBS, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa. Address correspondence to Prof. Kirwan, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK. E-mail: john.kirwan@bristol.ac.uk
Maarten Boers
From the University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; University of California, Geffen School of Medicine, Los Angeles, California, USA; Université de Lorraine, Université Paris Descartes, Nancy; Université Pierre et Marie Curie (UPMC), Paris; AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, the Netherlands; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds, Leeds, UK; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Seattle Rheumatology Associates, Swedish Medical Center Rheumatology Research Division, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Dr. Matteson is supported in part by grants from Novartis, the American College of Rheumatology, and the European League Against Rheumatism; and was a consultant to Horizon Pharmaceuticals; Dr. Singh received research grants from Takeda and Savient, consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals and Novartis; is a member of the OMERACT executive, which receives arms-length funding from 36 companies; and is a member of the American College of Rheumatology’s Guidelines Subcommittee of the Quality of Care Committee and the Veterans Affairs Rheumatology Field Advisory Committee. J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, and NIHR Leeds Musculoskeletal Biomedical Research Unit; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Furst, MD, University of California, Geffen School of Medicine; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes; L. Gossec, MD, PhD, UPMC—Paris 6, Groupe de Recherche Clinique-UPMC 08 (EEMOIS) and AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Kloppenburg, MD, PhD, Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; S.L. Mackie, PhD, MD, NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds; E.L. Matteson, MD, MPH, Division of Rheumatology, Mayo Clinic College of Medicine; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; P. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.A. Saketkoo, MD, MPH, Section of Rheumatology, Louisiana State University Health Sciences Center; L.S. Simon, MD, SDG LLC; J.A. Singh, MBBS, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa. Address correspondence to Prof. Kirwan, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK. E-mail: john.kirwan@bristol.ac.uk
Sarah Hewlett
From the University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; University of California, Geffen School of Medicine, Los Angeles, California, USA; Université de Lorraine, Université Paris Descartes, Nancy; Université Pierre et Marie Curie (UPMC), Paris; AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, the Netherlands; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds, Leeds, UK; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Seattle Rheumatology Associates, Swedish Medical Center Rheumatology Research Division, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Dr. Matteson is supported in part by grants from Novartis, the American College of Rheumatology, and the European League Against Rheumatism; and was a consultant to Horizon Pharmaceuticals; Dr. Singh received research grants from Takeda and Savient, consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals and Novartis; is a member of the OMERACT executive, which receives arms-length funding from 36 companies; and is a member of the American College of Rheumatology’s Guidelines Subcommittee of the Quality of Care Committee and the Veterans Affairs Rheumatology Field Advisory Committee. J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, and NIHR Leeds Musculoskeletal Biomedical Research Unit; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Furst, MD, University of California, Geffen School of Medicine; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes; L. Gossec, MD, PhD, UPMC—Paris 6, Groupe de Recherche Clinique-UPMC 08 (EEMOIS) and AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Kloppenburg, MD, PhD, Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; S.L. Mackie, PhD, MD, NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds; E.L. Matteson, MD, MPH, Division of Rheumatology, Mayo Clinic College of Medicine; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; P. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.A. Saketkoo, MD, MPH, Section of Rheumatology, Louisiana State University Health Sciences Center; L.S. Simon, MD, SDG LLC; J.A. Singh, MBBS, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa. Address correspondence to Prof. Kirwan, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK. E-mail: john.kirwan@bristol.ac.uk
Dorcas Beaton
From the University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; University of California, Geffen School of Medicine, Los Angeles, California, USA; Université de Lorraine, Université Paris Descartes, Nancy; Université Pierre et Marie Curie (UPMC), Paris; AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, the Netherlands; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds, Leeds, UK; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Seattle Rheumatology Associates, Swedish Medical Center Rheumatology Research Division, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Dr. Matteson is supported in part by grants from Novartis, the American College of Rheumatology, and the European League Against Rheumatism; and was a consultant to Horizon Pharmaceuticals; Dr. Singh received research grants from Takeda and Savient, consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals and Novartis; is a member of the OMERACT executive, which receives arms-length funding from 36 companies; and is a member of the American College of Rheumatology’s Guidelines Subcommittee of the Quality of Care Committee and the Veterans Affairs Rheumatology Field Advisory Committee. J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, and NIHR Leeds Musculoskeletal Biomedical Research Unit; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Furst, MD, University of California, Geffen School of Medicine; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes; L. Gossec, MD, PhD, UPMC—Paris 6, Groupe de Recherche Clinique-UPMC 08 (EEMOIS) and AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Kloppenburg, MD, PhD, Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; S.L. Mackie, PhD, MD, NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds; E.L. Matteson, MD, MPH, Division of Rheumatology, Mayo Clinic College of Medicine; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; P. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.A. Saketkoo, MD, MPH, Section of Rheumatology, Louisiana State University Health Sciences Center; L.S. Simon, MD, SDG LLC; J.A. Singh, MBBS, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa. Address correspondence to Prof. Kirwan, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK. E-mail: john.kirwan@bristol.ac.uk
Clifton O. Bingham III
From the University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; University of California, Geffen School of Medicine, Los Angeles, California, USA; Université de Lorraine, Université Paris Descartes, Nancy; Université Pierre et Marie Curie (UPMC), Paris; AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, the Netherlands; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds, Leeds, UK; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Seattle Rheumatology Associates, Swedish Medical Center Rheumatology Research Division, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Dr. Matteson is supported in part by grants from Novartis, the American College of Rheumatology, and the European League Against Rheumatism; and was a consultant to Horizon Pharmaceuticals; Dr. Singh received research grants from Takeda and Savient, consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals and Novartis; is a member of the OMERACT executive, which receives arms-length funding from 36 companies; and is a member of the American College of Rheumatology’s Guidelines Subcommittee of the Quality of Care Committee and the Veterans Affairs Rheumatology Field Advisory Committee. J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, and NIHR Leeds Musculoskeletal Biomedical Research Unit; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Furst, MD, University of California, Geffen School of Medicine; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes; L. Gossec, MD, PhD, UPMC—Paris 6, Groupe de Recherche Clinique-UPMC 08 (EEMOIS) and AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Kloppenburg, MD, PhD, Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; S.L. Mackie, PhD, MD, NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds; E.L. Matteson, MD, MPH, Division of Rheumatology, Mayo Clinic College of Medicine; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; P. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.A. Saketkoo, MD, MPH, Section of Rheumatology, Louisiana State University Health Sciences Center; L.S. Simon, MD, SDG LLC; J.A. Singh, MBBS, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa. Address correspondence to Prof. Kirwan, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK. E-mail: john.kirwan@bristol.ac.uk
Ernest Choy
From the University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; University of California, Geffen School of Medicine, Los Angeles, California, USA; Université de Lorraine, Université Paris Descartes, Nancy; Université Pierre et Marie Curie (UPMC), Paris; AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, the Netherlands; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds, Leeds, UK; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Seattle Rheumatology Associates, Swedish Medical Center Rheumatology Research Division, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Dr. Matteson is supported in part by grants from Novartis, the American College of Rheumatology, and the European League Against Rheumatism; and was a consultant to Horizon Pharmaceuticals; Dr. Singh received research grants from Takeda and Savient, consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals and Novartis; is a member of the OMERACT executive, which receives arms-length funding from 36 companies; and is a member of the American College of Rheumatology’s Guidelines Subcommittee of the Quality of Care Committee and the Veterans Affairs Rheumatology Field Advisory Committee. J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, and NIHR Leeds Musculoskeletal Biomedical Research Unit; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Furst, MD, University of California, Geffen School of Medicine; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes; L. Gossec, MD, PhD, UPMC—Paris 6, Groupe de Recherche Clinique-UPMC 08 (EEMOIS) and AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Kloppenburg, MD, PhD, Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; S.L. Mackie, PhD, MD, NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds; E.L. Matteson, MD, MPH, Division of Rheumatology, Mayo Clinic College of Medicine; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; P. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.A. Saketkoo, MD, MPH, Section of Rheumatology, Louisiana State University Health Sciences Center; L.S. Simon, MD, SDG LLC; J.A. Singh, MBBS, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa. Address correspondence to Prof. Kirwan, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK. E-mail: john.kirwan@bristol.ac.uk
Philip G. Conaghan
From the University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; University of California, Geffen School of Medicine, Los Angeles, California, USA; Université de Lorraine, Université Paris Descartes, Nancy; Université Pierre et Marie Curie (UPMC), Paris; AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, the Netherlands; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds, Leeds, UK; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Seattle Rheumatology Associates, Swedish Medical Center Rheumatology Research Division, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Dr. Matteson is supported in part by grants from Novartis, the American College of Rheumatology, and the European League Against Rheumatism; and was a consultant to Horizon Pharmaceuticals; Dr. Singh received research grants from Takeda and Savient, consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals and Novartis; is a member of the OMERACT executive, which receives arms-length funding from 36 companies; and is a member of the American College of Rheumatology’s Guidelines Subcommittee of the Quality of Care Committee and the Veterans Affairs Rheumatology Field Advisory Committee. J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, and NIHR Leeds Musculoskeletal Biomedical Research Unit; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Furst, MD, University of California, Geffen School of Medicine; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes; L. Gossec, MD, PhD, UPMC—Paris 6, Groupe de Recherche Clinique-UPMC 08 (EEMOIS) and AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Kloppenburg, MD, PhD, Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; S.L. Mackie, PhD, MD, NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds; E.L. Matteson, MD, MPH, Division of Rheumatology, Mayo Clinic College of Medicine; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; P. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.A. Saketkoo, MD, MPH, Section of Rheumatology, Louisiana State University Health Sciences Center; L.S. Simon, MD, SDG LLC; J.A. Singh, MBBS, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa. Address correspondence to Prof. Kirwan, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK. E-mail: john.kirwan@bristol.ac.uk
Maria-Antonietta D’Agostino
From the University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; University of California, Geffen School of Medicine, Los Angeles, California, USA; Université de Lorraine, Université Paris Descartes, Nancy; Université Pierre et Marie Curie (UPMC), Paris; AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, the Netherlands; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds, Leeds, UK; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Seattle Rheumatology Associates, Swedish Medical Center Rheumatology Research Division, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Dr. Matteson is supported in part by grants from Novartis, the American College of Rheumatology, and the European League Against Rheumatism; and was a consultant to Horizon Pharmaceuticals; Dr. Singh received research grants from Takeda and Savient, consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals and Novartis; is a member of the OMERACT executive, which receives arms-length funding from 36 companies; and is a member of the American College of Rheumatology’s Guidelines Subcommittee of the Quality of Care Committee and the Veterans Affairs Rheumatology Field Advisory Committee. J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, and NIHR Leeds Musculoskeletal Biomedical Research Unit; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Furst, MD, University of California, Geffen School of Medicine; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes; L. Gossec, MD, PhD, UPMC—Paris 6, Groupe de Recherche Clinique-UPMC 08 (EEMOIS) and AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Kloppenburg, MD, PhD, Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; S.L. Mackie, PhD, MD, NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds; E.L. Matteson, MD, MPH, Division of Rheumatology, Mayo Clinic College of Medicine; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; P. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.A. Saketkoo, MD, MPH, Section of Rheumatology, Louisiana State University Health Sciences Center; L.S. Simon, MD, SDG LLC; J.A. Singh, MBBS, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa. Address correspondence to Prof. Kirwan, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK. E-mail: john.kirwan@bristol.ac.uk
Maxime Dougados
From the University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; University of California, Geffen School of Medicine, Los Angeles, California, USA; Université de Lorraine, Université Paris Descartes, Nancy; Université Pierre et Marie Curie (UPMC), Paris; AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, the Netherlands; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds, Leeds, UK; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Seattle Rheumatology Associates, Swedish Medical Center Rheumatology Research Division, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Dr. Matteson is supported in part by grants from Novartis, the American College of Rheumatology, and the European League Against Rheumatism; and was a consultant to Horizon Pharmaceuticals; Dr. Singh received research grants from Takeda and Savient, consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals and Novartis; is a member of the OMERACT executive, which receives arms-length funding from 36 companies; and is a member of the American College of Rheumatology’s Guidelines Subcommittee of the Quality of Care Committee and the Veterans Affairs Rheumatology Field Advisory Committee. J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, and NIHR Leeds Musculoskeletal Biomedical Research Unit; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Furst, MD, University of California, Geffen School of Medicine; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes; L. Gossec, MD, PhD, UPMC—Paris 6, Groupe de Recherche Clinique-UPMC 08 (EEMOIS) and AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Kloppenburg, MD, PhD, Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; S.L. Mackie, PhD, MD, NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds; E.L. Matteson, MD, MPH, Division of Rheumatology, Mayo Clinic College of Medicine; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; P. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.A. Saketkoo, MD, MPH, Section of Rheumatology, Louisiana State University Health Sciences Center; L.S. Simon, MD, SDG LLC; J.A. Singh, MBBS, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa. Address correspondence to Prof. Kirwan, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK. E-mail: john.kirwan@bristol.ac.uk
Daniel E. Furst
From the University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; University of California, Geffen School of Medicine, Los Angeles, California, USA; Université de Lorraine, Université Paris Descartes, Nancy; Université Pierre et Marie Curie (UPMC), Paris; AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, the Netherlands; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds, Leeds, UK; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Seattle Rheumatology Associates, Swedish Medical Center Rheumatology Research Division, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Dr. Matteson is supported in part by grants from Novartis, the American College of Rheumatology, and the European League Against Rheumatism; and was a consultant to Horizon Pharmaceuticals; Dr. Singh received research grants from Takeda and Savient, consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals and Novartis; is a member of the OMERACT executive, which receives arms-length funding from 36 companies; and is a member of the American College of Rheumatology’s Guidelines Subcommittee of the Quality of Care Committee and the Veterans Affairs Rheumatology Field Advisory Committee. J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, and NIHR Leeds Musculoskeletal Biomedical Research Unit; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Furst, MD, University of California, Geffen School of Medicine; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes; L. Gossec, MD, PhD, UPMC—Paris 6, Groupe de Recherche Clinique-UPMC 08 (EEMOIS) and AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Kloppenburg, MD, PhD, Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; S.L. Mackie, PhD, MD, NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds; E.L. Matteson, MD, MPH, Division of Rheumatology, Mayo Clinic College of Medicine; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; P. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.A. Saketkoo, MD, MPH, Section of Rheumatology, Louisiana State University Health Sciences Center; L.S. Simon, MD, SDG LLC; J.A. Singh, MBBS, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa. Address correspondence to Prof. Kirwan, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK. E-mail: john.kirwan@bristol.ac.uk
Francis Guillemin
From the University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; University of California, Geffen School of Medicine, Los Angeles, California, USA; Université de Lorraine, Université Paris Descartes, Nancy; Université Pierre et Marie Curie (UPMC), Paris; AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, the Netherlands; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds, Leeds, UK; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Seattle Rheumatology Associates, Swedish Medical Center Rheumatology Research Division, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Dr. Matteson is supported in part by grants from Novartis, the American College of Rheumatology, and the European League Against Rheumatism; and was a consultant to Horizon Pharmaceuticals; Dr. Singh received research grants from Takeda and Savient, consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals and Novartis; is a member of the OMERACT executive, which receives arms-length funding from 36 companies; and is a member of the American College of Rheumatology’s Guidelines Subcommittee of the Quality of Care Committee and the Veterans Affairs Rheumatology Field Advisory Committee. J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, and NIHR Leeds Musculoskeletal Biomedical Research Unit; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Furst, MD, University of California, Geffen School of Medicine; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes; L. Gossec, MD, PhD, UPMC—Paris 6, Groupe de Recherche Clinique-UPMC 08 (EEMOIS) and AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Kloppenburg, MD, PhD, Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; S.L. Mackie, PhD, MD, NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds; E.L. Matteson, MD, MPH, Division of Rheumatology, Mayo Clinic College of Medicine; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; P. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.A. Saketkoo, MD, MPH, Section of Rheumatology, Louisiana State University Health Sciences Center; L.S. Simon, MD, SDG LLC; J.A. Singh, MBBS, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa. Address correspondence to Prof. Kirwan, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK. E-mail: john.kirwan@bristol.ac.uk
Laure Gossec
From the University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; University of California, Geffen School of Medicine, Los Angeles, California, USA; Université de Lorraine, Université Paris Descartes, Nancy; Université Pierre et Marie Curie (UPMC), Paris; AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, the Netherlands; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds, Leeds, UK; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Seattle Rheumatology Associates, Swedish Medical Center Rheumatology Research Division, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Dr. Matteson is supported in part by grants from Novartis, the American College of Rheumatology, and the European League Against Rheumatism; and was a consultant to Horizon Pharmaceuticals; Dr. Singh received research grants from Takeda and Savient, consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals and Novartis; is a member of the OMERACT executive, which receives arms-length funding from 36 companies; and is a member of the American College of Rheumatology’s Guidelines Subcommittee of the Quality of Care Committee and the Veterans Affairs Rheumatology Field Advisory Committee. J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, and NIHR Leeds Musculoskeletal Biomedical Research Unit; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Furst, MD, University of California, Geffen School of Medicine; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes; L. Gossec, MD, PhD, UPMC—Paris 6, Groupe de Recherche Clinique-UPMC 08 (EEMOIS) and AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Kloppenburg, MD, PhD, Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; S.L. Mackie, PhD, MD, NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds; E.L. Matteson, MD, MPH, Division of Rheumatology, Mayo Clinic College of Medicine; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; P. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.A. Saketkoo, MD, MPH, Section of Rheumatology, Louisiana State University Health Sciences Center; L.S. Simon, MD, SDG LLC; J.A. Singh, MBBS, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa. Address correspondence to Prof. Kirwan, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK. E-mail: john.kirwan@bristol.ac.uk
Désirée M. van der Heijde
From the University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; University of California, Geffen School of Medicine, Los Angeles, California, USA; Université de Lorraine, Université Paris Descartes, Nancy; Université Pierre et Marie Curie (UPMC), Paris; AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, the Netherlands; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds, Leeds, UK; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Seattle Rheumatology Associates, Swedish Medical Center Rheumatology Research Division, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Dr. Matteson is supported in part by grants from Novartis, the American College of Rheumatology, and the European League Against Rheumatism; and was a consultant to Horizon Pharmaceuticals; Dr. Singh received research grants from Takeda and Savient, consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals and Novartis; is a member of the OMERACT executive, which receives arms-length funding from 36 companies; and is a member of the American College of Rheumatology’s Guidelines Subcommittee of the Quality of Care Committee and the Veterans Affairs Rheumatology Field Advisory Committee. J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, and NIHR Leeds Musculoskeletal Biomedical Research Unit; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Furst, MD, University of California, Geffen School of Medicine; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes; L. Gossec, MD, PhD, UPMC—Paris 6, Groupe de Recherche Clinique-UPMC 08 (EEMOIS) and AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Kloppenburg, MD, PhD, Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; S.L. Mackie, PhD, MD, NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds; E.L. Matteson, MD, MPH, Division of Rheumatology, Mayo Clinic College of Medicine; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; P. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.A. Saketkoo, MD, MPH, Section of Rheumatology, Louisiana State University Health Sciences Center; L.S. Simon, MD, SDG LLC; J.A. Singh, MBBS, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa. Address correspondence to Prof. Kirwan, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK. E-mail: john.kirwan@bristol.ac.uk
Margreet Kloppenburg
From the University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; University of California, Geffen School of Medicine, Los Angeles, California, USA; Université de Lorraine, Université Paris Descartes, Nancy; Université Pierre et Marie Curie (UPMC), Paris; AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, the Netherlands; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds, Leeds, UK; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Seattle Rheumatology Associates, Swedish Medical Center Rheumatology Research Division, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Dr. Matteson is supported in part by grants from Novartis, the American College of Rheumatology, and the European League Against Rheumatism; and was a consultant to Horizon Pharmaceuticals; Dr. Singh received research grants from Takeda and Savient, consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals and Novartis; is a member of the OMERACT executive, which receives arms-length funding from 36 companies; and is a member of the American College of Rheumatology’s Guidelines Subcommittee of the Quality of Care Committee and the Veterans Affairs Rheumatology Field Advisory Committee. J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, and NIHR Leeds Musculoskeletal Biomedical Research Unit; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Furst, MD, University of California, Geffen School of Medicine; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes; L. Gossec, MD, PhD, UPMC—Paris 6, Groupe de Recherche Clinique-UPMC 08 (EEMOIS) and AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Kloppenburg, MD, PhD, Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; S.L. Mackie, PhD, MD, NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds; E.L. Matteson, MD, MPH, Division of Rheumatology, Mayo Clinic College of Medicine; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; P. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.A. Saketkoo, MD, MPH, Section of Rheumatology, Louisiana State University Health Sciences Center; L.S. Simon, MD, SDG LLC; J.A. Singh, MBBS, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa. Address correspondence to Prof. Kirwan, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK. E-mail: john.kirwan@bristol.ac.uk
Tore K. Kvien
From the University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; University of California, Geffen School of Medicine, Los Angeles, California, USA; Université de Lorraine, Université Paris Descartes, Nancy; Université Pierre et Marie Curie (UPMC), Paris; AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, the Netherlands; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds, Leeds, UK; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Seattle Rheumatology Associates, Swedish Medical Center Rheumatology Research Division, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Dr. Matteson is supported in part by grants from Novartis, the American College of Rheumatology, and the European League Against Rheumatism; and was a consultant to Horizon Pharmaceuticals; Dr. Singh received research grants from Takeda and Savient, consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals and Novartis; is a member of the OMERACT executive, which receives arms-length funding from 36 companies; and is a member of the American College of Rheumatology’s Guidelines Subcommittee of the Quality of Care Committee and the Veterans Affairs Rheumatology Field Advisory Committee. J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, and NIHR Leeds Musculoskeletal Biomedical Research Unit; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Furst, MD, University of California, Geffen School of Medicine; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes; L. Gossec, MD, PhD, UPMC—Paris 6, Groupe de Recherche Clinique-UPMC 08 (EEMOIS) and AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Kloppenburg, MD, PhD, Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; S.L. Mackie, PhD, MD, NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds; E.L. Matteson, MD, MPH, Division of Rheumatology, Mayo Clinic College of Medicine; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; P. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.A. Saketkoo, MD, MPH, Section of Rheumatology, Louisiana State University Health Sciences Center; L.S. Simon, MD, SDG LLC; J.A. Singh, MBBS, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa. Address correspondence to Prof. Kirwan, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK. E-mail: john.kirwan@bristol.ac.uk
Robert B.M. Landewé
From the University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; University of California, Geffen School of Medicine, Los Angeles, California, USA; Université de Lorraine, Université Paris Descartes, Nancy; Université Pierre et Marie Curie (UPMC), Paris; AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, the Netherlands; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds, Leeds, UK; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Seattle Rheumatology Associates, Swedish Medical Center Rheumatology Research Division, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Dr. Matteson is supported in part by grants from Novartis, the American College of Rheumatology, and the European League Against Rheumatism; and was a consultant to Horizon Pharmaceuticals; Dr. Singh received research grants from Takeda and Savient, consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals and Novartis; is a member of the OMERACT executive, which receives arms-length funding from 36 companies; and is a member of the American College of Rheumatology’s Guidelines Subcommittee of the Quality of Care Committee and the Veterans Affairs Rheumatology Field Advisory Committee. J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, and NIHR Leeds Musculoskeletal Biomedical Research Unit; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Furst, MD, University of California, Geffen School of Medicine; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes; L. Gossec, MD, PhD, UPMC—Paris 6, Groupe de Recherche Clinique-UPMC 08 (EEMOIS) and AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Kloppenburg, MD, PhD, Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; S.L. Mackie, PhD, MD, NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds; E.L. Matteson, MD, MPH, Division of Rheumatology, Mayo Clinic College of Medicine; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; P. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.A. Saketkoo, MD, MPH, Section of Rheumatology, Louisiana State University Health Sciences Center; L.S. Simon, MD, SDG LLC; J.A. Singh, MBBS, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa. Address correspondence to Prof. Kirwan, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK. E-mail: john.kirwan@bristol.ac.uk
Sarah L. Mackie
From the University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; University of California, Geffen School of Medicine, Los Angeles, California, USA; Université de Lorraine, Université Paris Descartes, Nancy; Université Pierre et Marie Curie (UPMC), Paris; AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, the Netherlands; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds, Leeds, UK; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Seattle Rheumatology Associates, Swedish Medical Center Rheumatology Research Division, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Dr. Matteson is supported in part by grants from Novartis, the American College of Rheumatology, and the European League Against Rheumatism; and was a consultant to Horizon Pharmaceuticals; Dr. Singh received research grants from Takeda and Savient, consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals and Novartis; is a member of the OMERACT executive, which receives arms-length funding from 36 companies; and is a member of the American College of Rheumatology’s Guidelines Subcommittee of the Quality of Care Committee and the Veterans Affairs Rheumatology Field Advisory Committee. J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, and NIHR Leeds Musculoskeletal Biomedical Research Unit; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Furst, MD, University of California, Geffen School of Medicine; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes; L. Gossec, MD, PhD, UPMC—Paris 6, Groupe de Recherche Clinique-UPMC 08 (EEMOIS) and AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Kloppenburg, MD, PhD, Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; S.L. Mackie, PhD, MD, NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds; E.L. Matteson, MD, MPH, Division of Rheumatology, Mayo Clinic College of Medicine; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; P. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.A. Saketkoo, MD, MPH, Section of Rheumatology, Louisiana State University Health Sciences Center; L.S. Simon, MD, SDG LLC; J.A. Singh, MBBS, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa. Address correspondence to Prof. Kirwan, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK. E-mail: john.kirwan@bristol.ac.uk
Eric L. Matteson
From the University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; University of California, Geffen School of Medicine, Los Angeles, California, USA; Université de Lorraine, Université Paris Descartes, Nancy; Université Pierre et Marie Curie (UPMC), Paris; AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, the Netherlands; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds, Leeds, UK; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Seattle Rheumatology Associates, Swedish Medical Center Rheumatology Research Division, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Dr. Matteson is supported in part by grants from Novartis, the American College of Rheumatology, and the European League Against Rheumatism; and was a consultant to Horizon Pharmaceuticals; Dr. Singh received research grants from Takeda and Savient, consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals and Novartis; is a member of the OMERACT executive, which receives arms-length funding from 36 companies; and is a member of the American College of Rheumatology’s Guidelines Subcommittee of the Quality of Care Committee and the Veterans Affairs Rheumatology Field Advisory Committee. J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, and NIHR Leeds Musculoskeletal Biomedical Research Unit; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Furst, MD, University of California, Geffen School of Medicine; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes; L. Gossec, MD, PhD, UPMC—Paris 6, Groupe de Recherche Clinique-UPMC 08 (EEMOIS) and AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Kloppenburg, MD, PhD, Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; S.L. Mackie, PhD, MD, NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds; E.L. Matteson, MD, MPH, Division of Rheumatology, Mayo Clinic College of Medicine; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; P. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.A. Saketkoo, MD, MPH, Section of Rheumatology, Louisiana State University Health Sciences Center; L.S. Simon, MD, SDG LLC; J.A. Singh, MBBS, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa. Address correspondence to Prof. Kirwan, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK. E-mail: john.kirwan@bristol.ac.uk
Philip J. Mease
From the University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; University of California, Geffen School of Medicine, Los Angeles, California, USA; Université de Lorraine, Université Paris Descartes, Nancy; Université Pierre et Marie Curie (UPMC), Paris; AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, the Netherlands; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds, Leeds, UK; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Seattle Rheumatology Associates, Swedish Medical Center Rheumatology Research Division, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Dr. Matteson is supported in part by grants from Novartis, the American College of Rheumatology, and the European League Against Rheumatism; and was a consultant to Horizon Pharmaceuticals; Dr. Singh received research grants from Takeda and Savient, consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals and Novartis; is a member of the OMERACT executive, which receives arms-length funding from 36 companies; and is a member of the American College of Rheumatology’s Guidelines Subcommittee of the Quality of Care Committee and the Veterans Affairs Rheumatology Field Advisory Committee. J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, and NIHR Leeds Musculoskeletal Biomedical Research Unit; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Furst, MD, University of California, Geffen School of Medicine; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes; L. Gossec, MD, PhD, UPMC—Paris 6, Groupe de Recherche Clinique-UPMC 08 (EEMOIS) and AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Kloppenburg, MD, PhD, Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; S.L. Mackie, PhD, MD, NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds; E.L. Matteson, MD, MPH, Division of Rheumatology, Mayo Clinic College of Medicine; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; P. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.A. Saketkoo, MD, MPH, Section of Rheumatology, Louisiana State University Health Sciences Center; L.S. Simon, MD, SDG LLC; J.A. Singh, MBBS, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa. Address correspondence to Prof. Kirwan, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK. E-mail: john.kirwan@bristol.ac.uk
Peter A. Merkel
From the University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; University of California, Geffen School of Medicine, Los Angeles, California, USA; Université de Lorraine, Université Paris Descartes, Nancy; Université Pierre et Marie Curie (UPMC), Paris; AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, the Netherlands; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds, Leeds, UK; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Seattle Rheumatology Associates, Swedish Medical Center Rheumatology Research Division, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Dr. Matteson is supported in part by grants from Novartis, the American College of Rheumatology, and the European League Against Rheumatism; and was a consultant to Horizon Pharmaceuticals; Dr. Singh received research grants from Takeda and Savient, consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals and Novartis; is a member of the OMERACT executive, which receives arms-length funding from 36 companies; and is a member of the American College of Rheumatology’s Guidelines Subcommittee of the Quality of Care Committee and the Veterans Affairs Rheumatology Field Advisory Committee. J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, and NIHR Leeds Musculoskeletal Biomedical Research Unit; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Furst, MD, University of California, Geffen School of Medicine; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes; L. Gossec, MD, PhD, UPMC—Paris 6, Groupe de Recherche Clinique-UPMC 08 (EEMOIS) and AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Kloppenburg, MD, PhD, Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; S.L. Mackie, PhD, MD, NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds; E.L. Matteson, MD, MPH, Division of Rheumatology, Mayo Clinic College of Medicine; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; P. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.A. Saketkoo, MD, MPH, Section of Rheumatology, Louisiana State University Health Sciences Center; L.S. Simon, MD, SDG LLC; J.A. Singh, MBBS, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa. Address correspondence to Prof. Kirwan, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK. E-mail: john.kirwan@bristol.ac.uk
Mikkel Ostergaard
From the University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; University of California, Geffen School of Medicine, Los Angeles, California, USA; Université de Lorraine, Université Paris Descartes, Nancy; Université Pierre et Marie Curie (UPMC), Paris; AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, the Netherlands; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds, Leeds, UK; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Seattle Rheumatology Associates, Swedish Medical Center Rheumatology Research Division, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Dr. Matteson is supported in part by grants from Novartis, the American College of Rheumatology, and the European League Against Rheumatism; and was a consultant to Horizon Pharmaceuticals; Dr. Singh received research grants from Takeda and Savient, consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals and Novartis; is a member of the OMERACT executive, which receives arms-length funding from 36 companies; and is a member of the American College of Rheumatology’s Guidelines Subcommittee of the Quality of Care Committee and the Veterans Affairs Rheumatology Field Advisory Committee. J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, and NIHR Leeds Musculoskeletal Biomedical Research Unit; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Furst, MD, University of California, Geffen School of Medicine; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes; L. Gossec, MD, PhD, UPMC—Paris 6, Groupe de Recherche Clinique-UPMC 08 (EEMOIS) and AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Kloppenburg, MD, PhD, Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; S.L. Mackie, PhD, MD, NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds; E.L. Matteson, MD, MPH, Division of Rheumatology, Mayo Clinic College of Medicine; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; P. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.A. Saketkoo, MD, MPH, Section of Rheumatology, Louisiana State University Health Sciences Center; L.S. Simon, MD, SDG LLC; J.A. Singh, MBBS, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa. Address correspondence to Prof. Kirwan, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK. E-mail: john.kirwan@bristol.ac.uk
Lesley Ann Saketkoo
From the University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; University of California, Geffen School of Medicine, Los Angeles, California, USA; Université de Lorraine, Université Paris Descartes, Nancy; Université Pierre et Marie Curie (UPMC), Paris; AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, the Netherlands; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds, Leeds, UK; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Seattle Rheumatology Associates, Swedish Medical Center Rheumatology Research Division, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Dr. Matteson is supported in part by grants from Novartis, the American College of Rheumatology, and the European League Against Rheumatism; and was a consultant to Horizon Pharmaceuticals; Dr. Singh received research grants from Takeda and Savient, consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals and Novartis; is a member of the OMERACT executive, which receives arms-length funding from 36 companies; and is a member of the American College of Rheumatology’s Guidelines Subcommittee of the Quality of Care Committee and the Veterans Affairs Rheumatology Field Advisory Committee. J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, and NIHR Leeds Musculoskeletal Biomedical Research Unit; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Furst, MD, University of California, Geffen School of Medicine; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes; L. Gossec, MD, PhD, UPMC—Paris 6, Groupe de Recherche Clinique-UPMC 08 (EEMOIS) and AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Kloppenburg, MD, PhD, Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; S.L. Mackie, PhD, MD, NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds; E.L. Matteson, MD, MPH, Division of Rheumatology, Mayo Clinic College of Medicine; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; P. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.A. Saketkoo, MD, MPH, Section of Rheumatology, Louisiana State University Health Sciences Center; L.S. Simon, MD, SDG LLC; J.A. Singh, MBBS, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa. Address correspondence to Prof. Kirwan, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK. E-mail: john.kirwan@bristol.ac.uk
Lee Simon
From the University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; University of California, Geffen School of Medicine, Los Angeles, California, USA; Université de Lorraine, Université Paris Descartes, Nancy; Université Pierre et Marie Curie (UPMC), Paris; AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, the Netherlands; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds, Leeds, UK; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Seattle Rheumatology Associates, Swedish Medical Center Rheumatology Research Division, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Dr. Matteson is supported in part by grants from Novartis, the American College of Rheumatology, and the European League Against Rheumatism; and was a consultant to Horizon Pharmaceuticals; Dr. Singh received research grants from Takeda and Savient, consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals and Novartis; is a member of the OMERACT executive, which receives arms-length funding from 36 companies; and is a member of the American College of Rheumatology’s Guidelines Subcommittee of the Quality of Care Committee and the Veterans Affairs Rheumatology Field Advisory Committee. J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, and NIHR Leeds Musculoskeletal Biomedical Research Unit; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Furst, MD, University of California, Geffen School of Medicine; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes; L. Gossec, MD, PhD, UPMC—Paris 6, Groupe de Recherche Clinique-UPMC 08 (EEMOIS) and AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Kloppenburg, MD, PhD, Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; S.L. Mackie, PhD, MD, NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds; E.L. Matteson, MD, MPH, Division of Rheumatology, Mayo Clinic College of Medicine; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; P. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.A. Saketkoo, MD, MPH, Section of Rheumatology, Louisiana State University Health Sciences Center; L.S. Simon, MD, SDG LLC; J.A. Singh, MBBS, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa. Address correspondence to Prof. Kirwan, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK. E-mail: john.kirwan@bristol.ac.uk
Jasvinder A. Singh
From the University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; University of California, Geffen School of Medicine, Los Angeles, California, USA; Université de Lorraine, Université Paris Descartes, Nancy; Université Pierre et Marie Curie (UPMC), Paris; AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, the Netherlands; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds, Leeds, UK; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Seattle Rheumatology Associates, Swedish Medical Center Rheumatology Research Division, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Dr. Matteson is supported in part by grants from Novartis, the American College of Rheumatology, and the European League Against Rheumatism; and was a consultant to Horizon Pharmaceuticals; Dr. Singh received research grants from Takeda and Savient, consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals and Novartis; is a member of the OMERACT executive, which receives arms-length funding from 36 companies; and is a member of the American College of Rheumatology’s Guidelines Subcommittee of the Quality of Care Committee and the Veterans Affairs Rheumatology Field Advisory Committee. J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, and NIHR Leeds Musculoskeletal Biomedical Research Unit; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Furst, MD, University of California, Geffen School of Medicine; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes; L. Gossec, MD, PhD, UPMC—Paris 6, Groupe de Recherche Clinique-UPMC 08 (EEMOIS) and AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Kloppenburg, MD, PhD, Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; S.L. Mackie, PhD, MD, NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds; E.L. Matteson, MD, MPH, Division of Rheumatology, Mayo Clinic College of Medicine; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; P. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.A. Saketkoo, MD, MPH, Section of Rheumatology, Louisiana State University Health Sciences Center; L.S. Simon, MD, SDG LLC; J.A. Singh, MBBS, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa. Address correspondence to Prof. Kirwan, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK. E-mail: john.kirwan@bristol.ac.uk
Vibeke Strand
From the University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; University of California, Geffen School of Medicine, Los Angeles, California, USA; Université de Lorraine, Université Paris Descartes, Nancy; Université Pierre et Marie Curie (UPMC), Paris; AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, the Netherlands; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds, Leeds, UK; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Seattle Rheumatology Associates, Swedish Medical Center Rheumatology Research Division, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Dr. Matteson is supported in part by grants from Novartis, the American College of Rheumatology, and the European League Against Rheumatism; and was a consultant to Horizon Pharmaceuticals; Dr. Singh received research grants from Takeda and Savient, consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals and Novartis; is a member of the OMERACT executive, which receives arms-length funding from 36 companies; and is a member of the American College of Rheumatology’s Guidelines Subcommittee of the Quality of Care Committee and the Veterans Affairs Rheumatology Field Advisory Committee. J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, and NIHR Leeds Musculoskeletal Biomedical Research Unit; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Furst, MD, University of California, Geffen School of Medicine; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes; L. Gossec, MD, PhD, UPMC—Paris 6, Groupe de Recherche Clinique-UPMC 08 (EEMOIS) and AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Kloppenburg, MD, PhD, Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; S.L. Mackie, PhD, MD, NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds; E.L. Matteson, MD, MPH, Division of Rheumatology, Mayo Clinic College of Medicine; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; P. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.A. Saketkoo, MD, MPH, Section of Rheumatology, Louisiana State University Health Sciences Center; L.S. Simon, MD, SDG LLC; J.A. Singh, MBBS, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa. Address correspondence to Prof. Kirwan, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK. E-mail: john.kirwan@bristol.ac.uk
Peter Tugwell
From the University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; University of California, Geffen School of Medicine, Los Angeles, California, USA; Université de Lorraine, Université Paris Descartes, Nancy; Université Pierre et Marie Curie (UPMC), Paris; AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, the Netherlands; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds, Leeds, UK; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Seattle Rheumatology Associates, Swedish Medical Center Rheumatology Research Division, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Dr. Matteson is supported in part by grants from Novartis, the American College of Rheumatology, and the European League Against Rheumatism; and was a consultant to Horizon Pharmaceuticals; Dr. Singh received research grants from Takeda and Savient, consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals and Novartis; is a member of the OMERACT executive, which receives arms-length funding from 36 companies; and is a member of the American College of Rheumatology’s Guidelines Subcommittee of the Quality of Care Committee and the Veterans Affairs Rheumatology Field Advisory Committee. J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, and NIHR Leeds Musculoskeletal Biomedical Research Unit; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Furst, MD, University of California, Geffen School of Medicine; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes; L. Gossec, MD, PhD, UPMC—Paris 6, Groupe de Recherche Clinique-UPMC 08 (EEMOIS) and AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Kloppenburg, MD, PhD, Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; S.L. Mackie, PhD, MD, NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds; E.L. Matteson, MD, MPH, Division of Rheumatology, Mayo Clinic College of Medicine; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; P. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.A. Saketkoo, MD, MPH, Section of Rheumatology, Louisiana State University Health Sciences Center; L.S. Simon, MD, SDG LLC; J.A. Singh, MBBS, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa. Address correspondence to Prof. Kirwan, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK. E-mail: john.kirwan@bristol.ac.uk
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Updating the OMERACT Filter: Core Areas as a Basis for Defining Core Outcome Sets
John R. Kirwan, Maarten Boers, Sarah Hewlett, Dorcas Beaton, Clifton O. Bingham, Ernest Choy, Philip G. Conaghan, Maria-Antonietta D’Agostino, Maxime Dougados, Daniel E. Furst, Francis Guillemin, Laure Gossec, Désirée M. van der Heijde, Margreet Kloppenburg, Tore K. Kvien, Robert B.M. Landewé, Sarah L. Mackie, Eric L. Matteson, Philip J. Mease, Peter A. Merkel, Mikkel Ostergaard, Lesley Ann Saketkoo, Lee Simon, Jasvinder A. Singh, Vibeke Strand, Peter Tugwell
The Journal of Rheumatology Mar 2014, jrheum.131309; DOI: 10.3899/jrheum.131309
Updating the OMERACT Filter: Core Areas as a Basis for Defining Core Outcome Sets
John R. Kirwan, Maarten Boers, Sarah Hewlett, Dorcas Beaton, Clifton O. Bingham, Ernest Choy, Philip G. Conaghan, Maria-Antonietta D’Agostino, Maxime Dougados, Daniel E. Furst, Francis Guillemin, Laure Gossec, Désirée M. van der Heijde, Margreet Kloppenburg, Tore K. Kvien, Robert B.M. Landewé, Sarah L. Mackie, Eric L. Matteson, Philip J. Mease, Peter A. Merkel, Mikkel Ostergaard, Lesley Ann Saketkoo, Lee Simon, Jasvinder A. Singh, Vibeke Strand, Peter Tugwell
The Journal of Rheumatology Mar 2014, jrheum.131309; DOI: 10.3899/jrheum.131309